These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 11220990)
21. Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk. Berger AP; Deibl M; Steiner H; Bektic J; Pelzer A; Spranger R; Klocker H; Bartsch G; Horninger W Prostate; 2005 Aug; 64(3):240-5. PubMed ID: 15712213 [TBL] [Abstract][Full Text] [Related]
26. [Free/total prostate specific antigen ratio (%PSA) to predict probability of prostate cancer]. Zenimoto M; Kita M; Arai T; Murayama T; Mori M Rinsho Byori; 2003 Oct; 51(10):969-73. PubMed ID: 14653195 [TBL] [Abstract][Full Text] [Related]
27. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening. Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715 [TBL] [Abstract][Full Text] [Related]
28. Prostate cancer screening with prostate-specific antigen in hemodialysis patients. Horinaga M; Kitamura K; Saito S; Ukimura O; Nakanoma T; Okihara K; Kitagawa M; Nakanishi H; Miki T Urol Int; 2007; 78(4):334-7. PubMed ID: 17495492 [TBL] [Abstract][Full Text] [Related]
29. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging. Coakley FV; Chen I; Qayyum A; Westphalen AC; Carroll PR; Hricak H; Chen MH; Kurhanewicz J BJU Int; 2007 Jan; 99(1):41-5. PubMed ID: 17227490 [TBL] [Abstract][Full Text] [Related]
30. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men. Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477 [TBL] [Abstract][Full Text] [Related]
31. [The usefulness of percentage of free prostate specific antigen/prostate specific antigen density in the diagnosis of prostate cancer]. Han G; Gao JP; Cao XL; Hong BF; Tang J Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):379-81. PubMed ID: 16638346 [TBL] [Abstract][Full Text] [Related]
32. Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer. Berger AP; Deibl M; Strasak A; Bektic J; Pelzer AE; Klocker H; Steiner H; Fritsche G; Bartsch G; Horninger W Urology; 2007 Jan; 69(1):134-8. PubMed ID: 17270635 [TBL] [Abstract][Full Text] [Related]
33. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer. Lehrer S; Diamond EJ; Stagger S; Stone NN; Stock RG Br J Cancer; 2002 Sep; 87(7):726-8. PubMed ID: 12232754 [TBL] [Abstract][Full Text] [Related]
34. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL. Terakawa T; Miyake H; Kanomata N; Kumano M; Takenaka A; Fujisawao M Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081 [TBL] [Abstract][Full Text] [Related]
35. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases. Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448 [TBL] [Abstract][Full Text] [Related]
37. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density. Men S; Cakar B; Conkbayir I; Hekimoglu B J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539 [TBL] [Abstract][Full Text] [Related]
38. [Prostate-specific antigen: an evaluation 15 years after its discovery]. Janssen T; Schulman C Prog Urol; 1994 Apr; 4(2):171-80. PubMed ID: 7515305 [TBL] [Abstract][Full Text] [Related]
39. [Place of surveillance in the treatment of localized prostate cancer]. Ravery V; Boccon-Gibod L Prog Urol; 1999 Apr; 9(2):225-30; discussion 229-30. PubMed ID: 10370945 [TBL] [Abstract][Full Text] [Related]
40. The use of percent free PSA for early detection of prostate cancer. Potter SR; Reckwitz T; Partin AW J Androl; 1999; 20(4):449-53. PubMed ID: 10452585 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]